|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12345678910111213...110111» |
- | Enrollment change, Trial termination, Trial primary completion date: Assessment of Performance of [18F]-FES for Endometriosis Diagnosis (clinicaltrials.gov) - Sep 17, 2018
P2, N=31, Terminated, Sponsor: University Hospital, Angers
N=100 --> 31 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Apr 2016; not enough enrollement
- | Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1) (clinicaltrials.gov) - Sep 17, 2018
P=N/A, N=300, Completed, Sponsor: Hoffmann-La Roche
N=100 --> 31 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Apr 2016; not enough enrollement Active, not recruiting --> Completed
- | Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Follistim AQ Cartridge (follitropin beta) / Organon
Enrollment change, Trial termination: Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment (clinicaltrials.gov) - Sep 14, 2018
P=N/A, N=20, Terminated, Sponsor: St. Olavs Hospital
Active, not recruiting --> Completed N=150 --> 20 | Recruiting --> Terminated; principal investigator left for another job, project leader retired
- | lidocaine topical / Generic mfg.
Phase classification, Enrollment change, Trial primary completion date: Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia (clinicaltrials.gov) - Sep 13, 2018
P=N/A, N=108, Active, not recruiting, Sponsor: Universit
N=150 --> 20 | Recruiting --> Terminated; principal investigator left for another job, project leader retired Phase classification: P4 --> P=N/A | N=224 --> 108 | Trial primary completion date: Jul 2018 --> Mar 2018
- | Trial completion: Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study (clinicaltrials.gov) - Sep 13, 2018
P=N/A, N=24, Completed, Sponsor: University of Washington
Phase classification: P4 --> P=N/A | N=224 --> 108 | Trial primary completion date: Jul 2018 --> Mar 2018 Active, not recruiting --> Completed
- | Trial primary completion date: EnMotion, Embryo's Natural Motion (clinicaltrials.gov) - Sep 12, 2018
P=N/A, N=200, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Active, not recruiting --> Completed Trial primary completion date: Jul 2018 --> Oct 2018
- | Trial completion, Preclinical, Enrollment change, Trial completion date: Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation (clinicaltrials.gov) - Sep 12, 2018
P=N/A, N=323, Completed, Sponsor: Reproductive Medicine Associates of New Jersey
Trial primary completion date: Jul 2018 --> Oct 2018 Active, not recruiting --> Completed | N=600 --> 323 | Trial completion date: Dec 2018 --> Jul 2018
- | Mifeprex (mifepristone) / Danco Laboratories
Trial completion, Metastases: Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Sep 11, 2018
P1, N=31, Completed, Sponsor: University of Chicago
Active, not recruiting --> Completed | N=600 --> 323 | Trial completion date: Dec 2018 --> Jul 2018 Active, not recruiting --> Completed
- | defactinib (VS-6063) / Verastem
Enrollment closed, Combination therapy: Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer (clinicaltrials.gov) - Sep 10, 2018
P1, N=98, Active, not recruiting, Sponsor: Verastem, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion, Preclinical: Weight Management Intervention for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF) (clinicaltrials.gov) - Sep 7, 2018
P=N/A, N=317, Completed, Sponsor: Sahlgrenska University Hospital, Sweden
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Yervoy (ipilimumab) / Ono Pharma, BMS
Enrollment change: Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer (clinicaltrials.gov) - Sep 5, 2018
P1, N=26, Terminated, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed N=48 --> 26
- | Enrollment change, Trial completion date, Trial withdrawal: Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors (clinicaltrials.gov) - Sep 5, 2018
P4, N=0, Withdrawn, Sponsor: Institut Universitari Dexeus
N=48 --> 26 N=35 --> 0 | Trial completion date: Dec 2017 --> Dec 2018 | Suspended --> Withdrawn
- | Trial completion, Trial completion date, Trial initiation date, Trial primary completion date: FOSFORE: Perceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment (clinicaltrials.gov) - Sep 5, 2018
P=N/A, N=1000, Completed, Sponsor: Centre Hospitalier Universitaire de la R
N=35 --> 0 | Trial completion date: Dec 2017 --> Dec 2018 | Suspended --> Withdrawn Not yet recruiting --> Completed | Trial completion date: May 2018 --> Jun 2017 | Initiation date: Oct 2016 --> Feb 2017 | Trial primary completion date: May 2018 --> Jun 2017
- | Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population (clinicaltrials.gov) - Sep 4, 2018
P=N/A, N=0, Withdrawn, Sponsor: IVI Madrid
Not yet recruiting --> Completed | Trial completion date: May 2018 --> Jun 2017 | Initiation date: Oct 2016 --> Feb 2017 | Trial primary completion date: May 2018 --> Jun 2017 N=600 --> 0 | Trial completion date: Mar 2018 --> Mar 2019 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Dec 2018
- | Preclinical, Trial completion date, Trial termination: In Vitro Follicle Activation (clinicaltrials.gov) - Aug 29, 2018
P=N/A, N=2, Terminated, Sponsor: National Foundation for Fertility Research
N=600 --> 0 | Trial completion date: Mar 2018 --> Mar 2019 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Dec 2018 Trial completion date: Jul 2018 --> Jul 2017 | Active, not recruiting --> Terminated; Results were not promising
- | Trial completion: Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence (clinicaltrials.gov) - Aug 29, 2018
P=N/A, N=14, Completed, Sponsor: Rhode Island Hospital
Trial completion date: Jul 2018 --> Jul 2017 | Active, not recruiting --> Terminated; Results were not promising Active, not recruiting --> Completed
- | chlorhexidine gluconate / Generic mfg.
Trial completion: Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery (clinicaltrials.gov) - Aug 29, 2018
P3, N=1114, Completed, Sponsor: Richmond University Medical Center
Active, not recruiting --> Completed Recruiting --> Completed
- | Recentin (cediranib) / AstraZeneca
Trial completion, Metastases: Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer (clinicaltrials.gov) - Aug 29, 2018
P2, N=74, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Preclinical, Trial primary completion date: An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro (clinicaltrials.gov) - Aug 28, 2018
P=N/A, N=100, Completed, Sponsor: National Foundation for Fertility Research
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Aug 2018
- | Trial completion date: Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors (clinicaltrials.gov) - Aug 28, 2018
P2, N=20, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Aug 2018 Trial completion date: Mar 2012 --> Jun 2018
- | Trial completion, Trial completion date, Trial primary completion date: RESMO: Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy (clinicaltrials.gov) - Aug 27, 2018
P=N/A, N=90, Completed, Sponsor: University Hospital, Strasbourg, France
Trial completion date: Mar 2012 --> Jun 2018 Recruiting --> Completed | Trial completion date: Jan 2019 --> Jul 2018 | Trial primary completion date: Jan 2019 --> Jul 2018
- | Trial completion, Trial completion date, Trial initiation date, Trial primary completion date: Does "Aggressivity" of Endometriosis Correlate to Clinical History or Outcomes? (clinicaltrials.gov) - Aug 27, 2018
P=N/A, N=45, Completed, Sponsor: St. Louis University
Recruiting --> Completed | Trial completion date: Jan 2019 --> Jul 2018 | Trial primary completion date: Jan 2019 --> Jul 2018 Enrolling by invitation --> Completed | Trial completion date: Sep 2020 --> Sep 2016 | Initiation date: Sep 2016 --> Sep 2013 | Trial primary completion date: Sep 2020 --> Sep 2016
- | Trial completion date, Trial primary completion date: VESICOL: Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer (clinicaltrials.gov) - Aug 25, 2018
P=N/A, N=22, Completed, Sponsor: Institut de Cancérologie de Lorraine
Enrolling by invitation --> Completed | Trial completion date: Sep 2020 --> Sep 2016 | Initiation date: Sep 2016 --> Sep 2013 | Trial primary completion date: Sep 2020 --> Sep 2016 Trial completion date: Dec 2016 --> Aug 2016 | Trial primary completion date: Dec 2016 --> Aug 2016
- | DCVAC/OvCa / Sotio
Trial completion date: SOV02: Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma (clinicaltrials.gov) - Aug 24, 2018
P2, N=71, Completed, Sponsor: Sotio a.s.
Trial completion date: Dec 2016 --> Aug 2016 | Trial primary completion date: Dec 2016 --> Aug 2016 Trial completion date: Nov 2017 --> May 2017
- | Trial completion date, Trial primary completion date: Quantitative MRI for Functional Imaging of the Testis: A New Methodology for Evaluation of the Infertile Male (clinicaltrials.gov) - Aug 24, 2018
P=N/A, N=20, Enrolling by invitation, Sponsor: New York University School of Medicine
Trial completion date: Nov 2017 --> May 2017 Trial completion date: May 2018 --> Aug 2019 | Trial primary completion date: May 2018 --> Dec 2018
- ||| triptorelin / Generic mfg.
Trial completion, Surgery: A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months (clinicaltrials.gov) - Aug 24, 2018
P=N/A, N=402, Completed, Sponsor: Ipsen
Trial completion date: May 2018 --> Aug 2019 | Trial primary completion date: May 2018 --> Dec 2018 Active, not recruiting --> Completed
- | cisplatin / Generic mfg.
Enrollment change, Trial withdrawal: Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients (clinicaltrials.gov) - Aug 13, 2018
P2, N=0, Withdrawn, Sponsor: Korea Cancer Center Hospital
Active, not recruiting --> Completed N=72 --> 0 | Recruiting --> Withdrawn
- | Enrollment change, Trial completion date: Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients (clinicaltrials.gov) - Aug 10, 2018
P=N/A, N=30, Completed, Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
N=72 --> 0 | Recruiting --> Withdrawn N=50 --> 30 | Trial completion date: May 2014 --> May 2016
- | Trial completion, HEOR: AdolCHICA: Improving Adolescent Health Outcomes Through Preventive Care Transformation (clinicaltrials.gov) - Aug 9, 2018
P=N/A, N=2831, Completed, Sponsor: Indiana University
N=50 --> 30 | Trial completion date: May 2014 --> May 2016 Recruiting --> Completed
- | Trial completion: Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors (clinicaltrials.gov) - Aug 9, 2018
P2, N=52, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Preclinical, Enrollment change, Trial completion date: Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients (clinicaltrials.gov) - Aug 8, 2018
P3, N=60, Completed, Sponsor: KK Women's and Children's Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=280 --> 60 | Trial completion date: Jun 2017 --> Nov 2017
- | cabergoline / Generic mfg.
Biomarker, Trial completion, Enrollment change, Trial completion date: Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers (clinicaltrials.gov) - Aug 8, 2018
P3, N=46, Completed, Sponsor: KK Women's and Children's Hospital
Active, not recruiting --> Completed | N=280 --> 60 | Trial completion date: Jun 2017 --> Nov 2017 Active, not recruiting --> Completed | N=540 --> 46 | Trial completion date: Dec 2016 --> Jun 2016
- | Trial completion: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings (clinicaltrials.gov) - Aug 8, 2018
P=N/A, N=932, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed | N=540 --> 46 | Trial completion date: Dec 2016 --> Jun 2016 Recruiting --> Completed
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Multicomponent Intervention to Reduce Sexual Risk and Substance Use (clinicaltrials.gov) - Aug 7, 2018
P=N/A, N=143, Completed, Sponsor: Hunter College of City University of New York
Recruiting --> Completed Active, not recruiting --> Completed | N=240 --> 143 | Trial completion date: Jul 2018 --> Nov 2017 | Trial primary completion date: Apr 2018 --> Nov 2017
- | Biomarker, Trial completion, Phase classification, Enrollment change, Trial completion date: To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients. (clinicaltrials.gov) - Aug 7, 2018
P=N/A, N=124, Completed, Sponsor: KK Women's and Children's Hospital
Active, not recruiting --> Completed | N=240 --> 143 | Trial completion date: Jul 2018 --> Nov 2017 | Trial primary completion date: Apr 2018 --> Nov 2017 Recruiting --> Completed | Phase classification: P4 --> PN/A | N=300 --> 124 | Trial completion date: Apr 2017 --> May 2018
- | Menopur (menotropin) / Ferring
Trial completion date: A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur® (clinicaltrials.gov) - Aug 7, 2018
P=N/A, N=296, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Completed | Phase classification: P4 --> PN/A | N=300 --> 124 | Trial completion date: Apr 2017 --> May 2018 Trial completion date: Jul 2018 --> Jan 2019
- | Trial completion: STI Screening as a Combined HIV Prevention Platform for MSM in Peru (clinicaltrials.gov) - Aug 7, 2018
P=N/A, N=150, Completed, Sponsor: University of California, Los Angeles
Trial completion date: Jul 2018 --> Jan 2019 Active, not recruiting --> Completed
- | Trial completion date: Platelet Rich Plasma (PRP) for Vulvar Lichen Sclerosus (clinicaltrials.gov) - Aug 6, 2018
P=N/A, N=29, Active, not recruiting, Sponsor: Center for Vulvovaginal Disorders
Active, not recruiting --> Completed Trial completion date: Jun 2018 --> Sep 2018
- | Enrollment closed, Trial completion date, Trial primary completion date, Metastases: CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (clinicaltrials.gov) - Aug 3, 2018
P=N/A, N=100000, Active, not recruiting, Sponsor: CureOne
Trial completion date: Jun 2018 --> Sep 2018 Recruiting --> Active, not recruiting | Trial completion date: Oct 2024 --> Oct 2019 | Trial primary completion date: Oct 2021 --> Oct 2019
- | progesterone / Generic mfg.
Trial completion, Head-to-Head: Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer (clinicaltrials.gov) - Aug 2, 2018
P4, N=1139, Completed, Sponsor: Shady Grove Fertility Reproductive Science Center
Recruiting --> Active, not recruiting | Trial completion date: Oct 2024 --> Oct 2019 | Trial primary completion date: Oct 2021 --> Oct 2019 Active, not recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: M. D. Anderson Symptom Inventory - Ovarian Cancer (clinicaltrials.gov) - Aug 2, 2018
P=N/A, N=158, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2019 --> Jul 2018 | Trial primary completion date: Dec 2019 --> Jul 2018
- | triptorelin / Generic mfg.
Trial completion, Preclinical, Trial completion date, Trial initiation date, Trial primary completion date: Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients (clinicaltrials.gov) - Jul 31, 2018
P=N/A, N=88, Completed, Sponsor: Kasr El Aini Hospital
Active, not recruiting --> Completed | Trial completion date: Dec 2019 --> Jul 2018 | Trial primary completion date: Dec 2019 --> Jul 2018 Recruiting --> Completed | Trial completion date: May 2017 --> Aug 2017 | Trial primary completion date: Apr 2017 --> Aug 2017 | Initiation date: Aug 2015 --> Apr 2016
- | Trial completion, Enrollment change: Inflammation and Treatment of Bacterial Vaginosis Near Term (clinicaltrials.gov) - Jul 27, 2018
P=N/A, N=59, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed | Trial completion date: May 2017 --> Aug 2017 | Trial primary completion date: Apr 2017 --> Aug 2017 | Initiation date: Aug 2015 --> Apr 2016 Recruiting --> Completed | N=520 --> 59
- | Growtropin-II (somatropin biosimilar) - Dong / A
Trial completion: A Clinical Study to Assess the Efficacy and Safety of DA-3002 (clinicaltrials.gov) - Jul 27, 2018
P3, N=58, Completed, Sponsor: Dong-A ST Co., Ltd.
Recruiting --> Completed | N=520 --> 59 Active, not recruiting --> Completed
- ||||| metformin hydrochloride extended release / Generic mfg.
Trial completion: Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS) (clinicaltrials.gov) - Jul 27, 2018
P3, N=124, Completed, Sponsor: Dexa Medica Group
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion: Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (clinicaltrials.gov) - Jul 26, 2018
P=N/A, N=186, Completed, Sponsor: Institute of Tropical Medicine, Belgium
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Trial completion date: Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine (clinicaltrials.gov) - Jul 24, 2018
P=N/A, N=40, Completed, Sponsor: Centre Hospitalier Universitaire de Nice
Active, not recruiting --> Completed Not yet recruiting --> Completed | Trial completion date: Jan 2019 --> May 2018
- | folate-tubulysin (EC1456) / Novartis
Trial completion date, Surgery: An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery (clinicaltrials.gov) - Jul 24, 2018
P1, N=3, Active, not recruiting, Sponsor: Endocyte
Not yet recruiting --> Completed | Trial completion date: Jan 2019 --> May 2018 Trial completion date: Apr 2018 --> Aug 2018
- | Trial completion: Trans-perineal Trigger Point Dry Needling for Chronic Pelvic Pain (clinicaltrials.gov) - Jul 20, 2018
P=N/A, N=79, Completed, Sponsor: Cork University Hospital
Trial completion date: Apr 2018 --> Aug 2018 Active, not recruiting --> Completed
- | Enrollment change: Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Jul 20, 2018
P1/2, N=16, Completed, Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Active, not recruiting --> Completed N=70 --> 16